Torna al Registre Simple

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorPinato, David J.
dc.contributor.authorMurray, Sam M
dc.contributor.authorForner, Alejandro
dc.contributor.authorKaneko, Takahiro
dc.contributor.authorFessas, Petros
dc.contributor.authorToniutto, Pierluigi
dc.contributor.authorMinguez Rosique, Beatriz
dc.date.accessioned2022-05-02T13:16:26Z
dc.date.available2022-05-02T13:16:26Z
dc.date.issued2021-09-30
dc.identifier.citationPinato DJ, Murray SM, Forner A, Kaneko T, Fessas P, Toniutto P, et al. Trans-arterial chemoembolization as a loco-regional inducer of immunogenic cell death in hepatocellular carcinoma: implications for immunotherapy. J Immunother Cancer. 2021 Sep 30;9(9):e003311.
dc.identifier.issn2051-1426
dc.identifier.urihttps://hdl.handle.net/11351/7455
dc.descriptionImmunoteràpia; Neoplàsies hepàtiques
dc.description.sponsorshipDJP is supported by grant funding from the Wellcome Trust Strategic Fund (PS3416) and by the Cancer Research UK Postdoctoral bursary (C57701/A26137). AF is supported by grant from Instituto de Salud Carlos III (PI18/00542).
dc.language.isoeng
dc.publisherBMJ
dc.relation.ispartofseriesJournal for ImmunoTherapy of Cancer;9(9)
dc.rightsAttribution-NonCommercial 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.sourceScientia
dc.subjectFetge - Càncer - Tractament
dc.subjectHemostàtics
dc.subjectMort cel·lular
dc.subject.meshChemoembolization, Therapeutic
dc.subject.meshCarcinoma, Hepatocellular
dc.subject.mesh/drug therapy
dc.titleTrans-arterial chemoembolization as a loco-regional inducer of immunogenic cell death in hepatocellular carcinoma: implications for immunotherapy
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1136/jitc-2021-003311
dc.subject.decsquimioembolización terapéutica
dc.subject.decscarcinoma hepatocelular
dc.subject.decs/farmacoterapia
dc.relation.publishversionhttp://dx.doi.org/10.1136/jitc-2021-003311
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Pinato DJ] Department of Surgery & Cancer, Faculty of Medicine, Imperial College London, Hammersmith Hospital Campus, London, UK. Division of Oncology, Department of Translational Medicine, Universita del Piemonte Orientale "A. Avogadro", Novara, Italy. [Murray SM] Department of Infectious Diseases, Faculty of Medicine, Imperial College London, Hammersmith Hospital Campus, London, UK. [Forner A] Liver Unit, Barcelona Clinic Liver Cancer (BCLC) Group, University of Barcelona, Hospital Clinic, Barcelona, Spain. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III, Madrid, Spain. [Kaneko T] Tokyo Medical and Dental University, Bunkyo-ku, Japan. [Fessas P] Department of Surgery & Cancer, Faculty of Medicine, Imperial College London, Hammersmith Hospital Campus, London, UK. [Toniutto P] Hepatology and Liver Transplantation Unit, Department of Medical Area (DAME), University of Udine, Udine, Italy. [Mínguez B] Unitat del Fetge, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain
dc.identifier.pmid34593621
dc.identifier.wos000703191800004
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Fitxers en aquest element

Thumbnail
Thumbnail

Aquest element apareix en la col·lecció o col·leccions següent(s)

Torna al Registre Simple